Literature DB >> 18179924

Genetic factors are important determinants of neurodevelopmental outcome after repair of tetralogy of Fallot.

Ilana Zeltser1, Gail P Jarvik, Judy Bernbaum, Gil Wernovsky, Alex S Nord, Marsha Gerdes, Elaine Zackai, Robert Clancy, Susan C Nicolson, Thomas L Spray, J William Gaynor.   

Abstract

OBJECTIVE: Adverse neurodevelopmental sequelae are common in children with congenital heart defects. Tetralogy of Fallot is part of the clinical phenotype of many genetic syndromes. We evaluated the determinants of neurodevelopmental outcome in patients with tetralogy of Fallot.
METHODS: We performed a subgroup analysis of children with tetralogy of Fallot undergoing complete repair before 6 months of age who were enrolled in a trial assessing apolipoprotein E genotype as a predictor of neurodevelopmental outcome. Assessment included genetic evaluation, neurologic examination, and the Bayley Scales of Infant Development-II, yielding the Mental Developmental Index and Psychomotor Developmental Index.
RESULTS: Sixty children were tested at 1 year of age. A confirmed or suspected genetic syndrome was identified in 18.3%. The mean Mental Developmental Index was 89 +/- 13, and the mean Psychomotor Developmental Index was 81 +/- 17. Scores for the Mental Developmental Index (76 +/- 13 vs 92 +/- 11) and Psychomotor Developmental Index (63 +/- 13 vs 85 +/- 15) were significantly lower for patients with genetic syndromes. The presence of a genetic syndrome was a predictor of lower Mental Developmental Index and Psychomotor Developmental Index (P = .002 and P = .001). The presence of tetralogy of Fallot with pulmonary atresia and the apolipoprotein E epsilon2 allele were predictive of a lower Mental Developmental Index (P = .001 and P = .035). No other preoperative or operative variables were predictive of worse neurodevelopmental outcome.
CONCLUSIONS: At 1 year of age after repair of tetralogy of Fallot, most patients had neurodevelopmental scores within the normal range. Genetic syndromes and the apolipoprotein E epsilon2 allele were important risk factors for neurodevelopmental dysfunction and accounted for some interindividual differences in outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179924     DOI: 10.1016/j.jtcvs.2007.04.074

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Patterns of cardiac and extracardiac anomalies in adults with tetralogy of fallot.

Authors:  Sara Piran; Anne S Bassett; Jasmine Grewal; Jodi-Ann Swaby; Chantal Morel; Erwin N Oechslin; Andrew N Redington; Peter P Liu; Candice K Silversides
Journal:  Am Heart J       Date:  2011-01       Impact factor: 4.749

2.  Is cardiac diagnosis a predictor of neurodevelopmental outcome after cardiac surgery in infancy?

Authors:  J William Gaynor; Marsha Gerdes; Alex S Nord; Judy Bernbaum; Elaine Zackai; Gil Wernovsky; Robert R Clancy; Patrick J Heagerty; Cynthia B Solot; Donna McDonald-McGinn; Gail P Jarvik
Journal:  J Thorac Cardiovasc Surg       Date:  2010-10-15       Impact factor: 5.209

3.  Congenital Heart Defects and Receipt of Special Education Services.

Authors:  Tiffany Riehle-Colarusso; Andrew Autry; Hilda Razzaghi; Coleen A Boyle; William T Mahle; Kim Van Naarden Braun; Adolfo Correa
Journal:  Pediatrics       Date:  2015-08-17       Impact factor: 7.124

4.  Adolescents with tetralogy of Fallot: neuropsychological assessment and structural brain imaging.

Authors:  David C Bellinger; Michael J Rivkin; David DeMaso; Richard L Robertson; Christian Stopp; Carolyn Dunbar-Masterson; David Wypij; Jane W Newburger
Journal:  Cardiol Young       Date:  2014-02-11       Impact factor: 1.093

5.  A predictive model for neurodevelopmental outcome after the Norwood procedure.

Authors:  William T Mahle; Minmin Lu; Richard G Ohye; J William Gaynor; Caren S Goldberg; Lynn A Sleeper; Victoria L Pemberton; Kathleen A Mussatto; Ismee A Williams; Erica Sood; Catherine Dent Krawczeski; Alan Lewis; Nicole Mirarchi; Mark Scheurer; Sara K Pasquali; Nelangi Pinto; Jeffrey P Jacobs; Brian W McCrindle; Jane W Newburger
Journal:  Pediatr Cardiol       Date:  2012-08-03       Impact factor: 1.655

6.  Impact of Tight Glycemic Control on Neurodevelopmental Outcomes at 1 Year of Age for Children with Congenital Heart Disease: A Randomized Controlled Trial.

Authors:  Anjali Sadhwani; Lisa A Asaro; Caren Goldberg; Janice Ware; Jennifer Butcher; Michael Gaies; Cynthia Smith; Jamin L Alexander; David Wypij; Michael S D Agus
Journal:  J Pediatr       Date:  2016-04-23       Impact factor: 4.406

7.  Functional outcomes of adults with 22q11.2 deletion syndrome.

Authors:  Nancy J Butcher; Eva W C Chow; Gregory Costain; Dominique Karas; Andrew Ho; Anne S Bassett
Journal:  Genet Med       Date:  2012-06-28       Impact factor: 8.822

8.  Morbidity and mortality prediction in pediatric heart surgery: Physiological profiles and surgical complexity.

Authors:  John T Berger; Richard Holubkov; Ron Reeder; David L Wessel; Kathleen Meert; Robert A Berg; Michael J Bell; Robert Tamburro; J Michael Dean; Murray M Pollack
Journal:  J Thorac Cardiovasc Surg       Date:  2017-02-10       Impact factor: 5.209

9.  PINOT NOIR: pulmonic insufficiency improvement with nitric oxide inhalational response.

Authors:  Stephen A Hart; Ganesh P Devendra; Yuli Y Kim; Scott D Flamm; Vidyasagar Kalahasti; Janine Arruda; Esteban Walker; Thananya Boonyasirinant; Michael Bolen; Randolph Setser; Richard A Krasuski
Journal:  J Cardiovasc Magn Reson       Date:  2013-09-04       Impact factor: 5.364

10.  Results of genome-wide analyses on neurodevelopmental phenotypes at four-year follow-up following cardiac surgery in infancy.

Authors:  Daniel S Kim; Ian B Stanaway; Ramakrishnan Rajagopalan; Judy C Bernbaum; Cynthia B Solot; Nancy Burnham; Elaine H Zackai; Robert R Clancy; Susan C Nicolson; Marsha Gerdes; Deborah A Nickerson; Hakon Hakonarson; J William Gaynor; Gail P Jarvik
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.